193 related articles for article (PubMed ID: 10945497)
1. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
Jungbluth AA; Stockert E; Chen YT; Kolb D; Iversen K; Coplan K; Williamson B; Altorki N; Busam KJ; Old LJ
Br J Cancer; 2000 Aug; 83(4):493-7. PubMed ID: 10945497
[TBL] [Abstract][Full Text] [Related]
2. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.
Jungbluth AA; Chen YT; Busam KJ; Coplan K; Kolb D; Iversen K; Williamson B; Van Landeghem FK; Stockert E; Old LJ
Int J Cancer; 2002 Jun; 99(6):839-45. PubMed ID: 12115486
[TBL] [Abstract][Full Text] [Related]
3. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
[TBL] [Abstract][Full Text] [Related]
4. The tumour-associated antigen MAGE-1 is detectable in formalin-fixed paraffin sections of malignant melanoma.
Gudat F; Zuber M; Dürmüller U; Kocher T; Schaefer C; Noppen C; Spagnoli G
Virchows Arch; 1996 Oct; 429(2-3):77-81. PubMed ID: 8917707
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
[TBL] [Abstract][Full Text] [Related]
6. Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Zhuang R; Zhu Y; Fang L; Liu XS; Tian Y; Chen LH; Ouyang WM; Xu XG; Jian JL; Güre AO; Fortunato S; Ritter G; Old LJ; Simpson AJ; Chen YT; Jin B; Jungbluth AA
Cancer Immun; 2006 Apr; 6():7. PubMed ID: 16594646
[TBL] [Abstract][Full Text] [Related]
7. MAGE-A9 mRNA and protein expression in bladder cancer.
Picard V; Bergeron A; Larue H; Fradet Y
Int J Cancer; 2007 May; 120(10):2170-7. PubMed ID: 17290406
[TBL] [Abstract][Full Text] [Related]
8. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
Jungbluth AA; Antonescu CR; Busam KJ; Iversen K; Kolb D; Coplan K; Chen YT; Stockert E; Ladanyi M; Old LJ
Int J Cancer; 2001 Oct; 94(2):252-6. PubMed ID: 11668506
[TBL] [Abstract][Full Text] [Related]
9. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
10. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
11. MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
Schultz-Thater E; Piscuoglio S; Iezzi G; Le Magnen C; Zajac P; Carafa V; Terracciano L; Tornillo L; Spagnoli GC
Int J Cancer; 2011 Sep; 129(5):1137-48. PubMed ID: 21710496
[TBL] [Abstract][Full Text] [Related]
12. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
[TBL] [Abstract][Full Text] [Related]
13. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis (CT) antigens are expressed in fetal ovary.
Nelson PT; Zhang PJ; Spagnoli GC; Tomaszewski JE; Pasha TL; Frosina D; Caballero OL; Simpson AJ; Old LJ; Jungbluth AA
Cancer Immun; 2007 Jan; 7():1. PubMed ID: 17217256
[TBL] [Abstract][Full Text] [Related]
15. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S
J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802
[TBL] [Abstract][Full Text] [Related]
16. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
[TBL] [Abstract][Full Text] [Related]
17. Melanoma or not? Cancer testis antigens may help.
Lüftl M; Schuler G; Jungbluth AA
Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517
[TBL] [Abstract][Full Text] [Related]
18. Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
Lerut E; Van Poppel H; Joniau S; Gruselle O; Coche T; Therasse P
Int J Clin Exp Pathol; 2015; 8(8):9522-32. PubMed ID: 26464715
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the melanoma antigen gene (MAGE) in making the differential diagnosis between pleomorphic adenoma and adenoid cystic carcinoma.
Park JH; Do NY; Han SI; Lim SC
J Otolaryngol Head Neck Surg; 2012 Feb; 41(1):20-9. PubMed ID: 22498264
[TBL] [Abstract][Full Text] [Related]
20. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
